According to Medistim's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.28. At the end of 2024 the company had a P/S ratio of 4.81.
Year | P/S ratio | Change |
---|---|---|
2024 | 4.81 | -37.34% |
2023 | 7.68 | -10.43% |
2022 | 8.58 | -45.67% |
2021 | 15.8 | 10.64% |
2020 | 14.3 | 47.03% |
2019 | 9.70 | 156.8% |
2018 | 3.78 | -15.06% |
2017 | 4.45 | -9.22% |
2016 | 4.90 | 32.91% |
2015 | 3.69 | 80.51% |
2014 | 2.04 | -5.53% |
2013 | 2.16 | 5.96% |
2012 | 2.04 | -6.16% |
2011 | 2.17 | -27.69% |
2010 | 3.01 |